The PACE Study: physical activity facilitation for older adults

Not Applicable

Completed

• Conditions: Topic: Primary Care Research Network for England; Subtopic: Not Assigned; Disease: All Diseases; Not Applicable

• Registration Number: ISRCTN80470273
• Lead Sponsor: niversity of Bristol (UK)

Brief Summary

1. 2015 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25872500 2. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/30891309

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-10-25
• Study Completion: 2015-07-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

1. Male and female aged 65 years or older
2. Community-dwelling, including those in warden-controlled accommodation
3. Inactive: undertaking less than 150 minutes of moderate-to-vigorous physical activity per week
4. Non-disabled at baseline: able to complete a 4m walk at a speed of 0.8m/s or greater, without sitting, leaning, using walking aids or another person. This practical assessment is highly predictive (>90%) of successfully completing the well-established 400m walk test within 15 minutes
5. At risk of subsequent disability: scoring less than 10 out of 12 on the Short Physical Performance Battery (SPPB)

Exclusion Criteria

1. Unable to participate in the intervention or unable to complete the outcome assessments due to speech, language, or sensory problems
2. Resident in a nursing home
3. Plans to move outside of the study area within six months of the screening clinic visit or plans to be away for more than eight consecutive weeks during this period
4. Currently participating in exercise-on-prescription or a physical rehabilitation programme or study
5. A documented or patient-reported medical condition including but not limited to:
5.1. Severe uncontrolled arthritis, e.g. awaiting joint replacement, that would interfere with the ability to participate in the intervention arm
5.2. Lung disease requiring regular use of corticosteroids or of supplemental oxygen
5.3. Cardiovascular disease, including unstable angina, clinically significant valvular disease, uncontrolled and symptomatic cardiac arrhythmias, uncontrolled and symptomatic heart failure, suspected or known dissecting aneurysm
5.4. Past history of cardiac arrest or presence of an implantable cardiac defibrillator
5.5. Neuromuscular, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise
5.6. Moderate or severe cognitive impairment or dementia
5.7. Severe uncontrolled psychiatric illness
5.8. Multiple falls, i.e. two or more falls in the previous three months.
6. Investigator concern about an individual's safety or ability to adhere to the intervention if enrolled in the trial

Participants will not be medically screened for the above conditions, however they will be asked about the presence or absence of each condition on enrollment. It is important that no patient is inappropriately encouraged to participate in the trial and therefore the eligibility of each participant will be judged clinically by the investigator on a case-by-case basis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Short Physical Performance Battery (SPPB); Timepoint(s): At baseline: month 0, at follow-up: month 6